XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 21,038 $ 27,053
Marketable securities 7,360 7,137
Funds receivable from New Jersey net operating loss 33 1,676
Prepaid expenses and other current assets 438 455
Total current assets 28,869 36,321
Property and equipment, net 145 195
Right of use asset, net 781 829
Patent and trademark rights, net 2,038 1,941
Other assets 1,784 1,202
Total assets 33,617 40,488
Current liabilities:    
Accounts payable 2,151 377
Accrued expenses 528 806
Current portion of operating lease liability 206 178
Total current liabilities 2,885 1,361
Long-term liabilities:    
Operating lease liability 597 659
Commitments and contingencies (Notes 12 and 13)
Stockholders’ equity:    
Series B Convertible Preferred Stock, stated value $1,000 per share, 690 and 696 issued and outstanding, respectively 690 696
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; 48,419,491 and 48,084,287, issued and outstanding, respectively 48 48
Additional paid-in capital 418,513 418,270
Accumulated deficit (389,116) (380,546)
Total stockholders’ equity 30,135 38,468
Total liabilities and stockholders’ equity $ 33,617 $ 40,488